According to a new recommendation statement published in JAMA, the U.S. Preventive Services Task Force (USPSTF) recommends PrEP for those at high risk of contracting HIV to comprise newer antiretroviral drugs, including a long-acting option.

The prolonged use of PPI drugs, which are designed to control acid reflux and other gastrointestinal disorders, may raise the risk of dementia, according to a new study in Neurology.

According to new CDC data, the rate of vaccinations against measles, mumps, and rubella (MMR) for kindergarteners has fallen below the optimum target rate of 95% for the second year in a row, declining to 93%.

New survey findings from the American Society of Health-System Pharmacists (ASHP) shows that roughly 99% of health-system pharmacists said they are experiencing drug shortages. Nearly one-third of the respondents said the current shortages are “critically impactful,” causing facilities to delay, ration, or cancel procedures or treatments.

New findings from the SELECT trial indicate that semaglutide (Wegovy—Novo Nordisk) reduces the risk of major heart complications—heart attacks, strokes, and CV deaths—by 20%. The 5-year randomized trial of approximately 17,500 patients is the first to demonstrate that an obesity drug can have long-term CV benefits.